Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-03-29

Clinical Trial Update: Attenuation of Corticosteroid Induced Hippocampal Changes [Phase 4]

View source ↗

Summary

Phase 4 clinical trial documenting attenuation of corticosteroid-induced hippocampal changes in Organic Memory Impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Texas Southwestern Medical Center | Conditions: Organic Memory Impairment | Phase 4 | Status: COMPLETED | Results posted: 2019-03-29